Who assesses how well a drug works and the economic value that represents for patients? How is the clinical effectiveness of a drug for a certain condition assessed vs. its competitors - and a “fair price” established?
The Institute for Clinical and Economic Review (ICER) is an independent, nonprofit watchdog on drug pricing.
You’ve asked about ICER – now find out:
• What a value-based framework for drug pricing is
• How ICER evaluates CAR-T and other emerging therapies
• ICER’s comparative assessments of drugs for conditions like RA, MS and migraine
• How policymakers, employers, and other decision-makers are using ICER's work
~ This complimentary webinar is open to NEBGH Members only ~